TY  - JOUR
AU  - Carretero-González, Alberto
AU  - Otero, Irene
AU  - Lora, David
AU  - Carril-Ajuria, Lucía
AU  - Castellano, Daniel
AU  - de Velasco, Guillermo
PY  - 2021
DO  - 10.1080/2162402X.2021.1878599
UR  - https://hdl.handle.net/10668/25396
T2  - Oncoimmunology
AB  - Immune checkpoint inhibitors (ICIs) as monotherapy in different solid tumors showed an early detrimental effect in a subset of patients reflected by the early crossover of the progression-free survival (PFS) curves. Currently, combination therapies...
LA  - en
KW  - Immune checkpoint inhibitors
KW  - chemotherapy
KW  - efficacy
KW  - safety
KW  - targeted therapy
KW  - B7-H1 Antigen
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Neoplasms
KW  - Progression-Free Survival
KW  - Standard of Care
TI  - Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.
TY  - research article
VL  - 10
ER  -